v3.26.3
Segment Information - Schedule of Segment Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Segment Reporting [Line Items]        
Net revenue $ 862,684 $ 784,513 $ 2,381,400 $ 2,204,441
Cost of goods sold 528,566 510,539 1,392,661 1,388,323
Gross profit 334,118 273,974 988,739 816,118
Selling, general and administrative 139,645 137,815 427,227 380,369
Research and development 68,374 63,352 145,774 151,356
Intellectual property legal development expenses 2,193 2,437 5,822 6,221
Acquisition and integration costs 22,320 0 35,073 0
Restructuring and other charges 936 143 2,140 1,738
Change in fair value of contingent consideration (6,000) 0 (6,000) 0
Charges for property losses and associated expenses 5,369 0 5,369 0
Charges (credit) related to legal matters, net 6,497 0 15,248 (390)
Other operating income (631) (117) (8,870) (5,239)
Operating income 95,415 70,344 366,956 282,063
Affordable Medicines        
Segment Reporting [Line Items]        
Net revenue 547,109 460,741 1,460,259 1,308,874
AvKARE        
Segment Reporting [Line Items]        
Net revenue 165,313 198,532 488,319 533,987
Operating Segments | Affordable Medicines        
Segment Reporting [Line Items]        
Net revenue 547,109 460,741 1,460,259 1,308,874
Cost of goods sold 352,331 280,463 867,459 775,742
Gross profit 194,778 180,278 592,800 533,132
Selling, general and administrative 32,097 37,173 115,782 105,114
Research and development 63,418 55,124 129,727 128,003
Intellectual property legal development expenses 2,138 2,378 5,633 6,069
Acquisition and integration costs 0   0  
Restructuring and other charges 891 90 891 773
Change in fair value of contingent consideration (6,000)   (6,000)  
Charges for property losses and associated expenses 5,334   5,334  
Charges (credit) related to legal matters, net 5,500   14,251 (390)
Other operating income (631) (117) (8,870) (5,239)
Operating income 92,031 85,630 336,052 298,802
Operating Segments | Specialty        
Segment Reporting [Line Items]        
Net revenue 150,262 125,240 432,822 361,580
Cost of goods sold 46,212 73,808 137,497 182,686
Gross profit 104,050 51,432 295,325 178,894
Selling, general and administrative 36,969 33,580 111,755 94,872
Research and development 4,956 8,228 16,047 23,353
Intellectual property legal development expenses 55 59 189 152
Acquisition and integration costs 0   0  
Restructuring and other charges 0 0 347 471
Change in fair value of contingent consideration 0   0  
Charges for property losses and associated expenses 35   35  
Charges (credit) related to legal matters, net 1,000   1,000 0
Other operating income 0 0 0 0
Operating income 61,035 9,565 165,952 60,046
Operating Segments | AvKARE        
Segment Reporting [Line Items]        
Net revenue 165,313 198,532 488,319 533,987
Cost of goods sold 130,023 156,268 387,705 429,895
Gross profit 35,290 42,264 100,614 104,092
Selling, general and administrative 17,919 15,234 51,512 46,007
Research and development 0 0 0 0
Intellectual property legal development expenses 0 0 0 0
Acquisition and integration costs 0   0  
Restructuring and other charges 0 0 0 0
Change in fair value of contingent consideration 0   0  
Charges for property losses and associated expenses 0   0  
Charges (credit) related to legal matters, net 0   0 0
Other operating income 0 0 0 0
Operating income 17,371 27,030 49,102 58,085
Corporate and Other        
Segment Reporting [Line Items]        
Net revenue 0 0 0 0
Cost of goods sold 0 0 0 0
Gross profit 0 0 0 0
Selling, general and administrative 52,660 51,828 148,178 134,376
Research and development 0 0 0 0
Intellectual property legal development expenses 0 0 0 0
Acquisition and integration costs 22,320   35,073  
Restructuring and other charges 45 53 902 494
Change in fair value of contingent consideration 0   0  
Charges for property losses and associated expenses 0   0  
Charges (credit) related to legal matters, net (3)   (3) 0
Other operating income 0 0 0 0
Operating income $ (75,022) $ (51,881) $ (184,150) $ (134,870)